<DOC>
	<DOC>NCT03103763</DOC>
	<brief_summary>This study is designed to evaluate the efficacy and safety of warfarin anticoagulation in the very old and attempt to identify risk factors which may impede safe and effective anticoagulation.</brief_summary>
	<brief_title>Anticoagulation Therapy in the Very Old</brief_title>
	<detailed_description>This is a prospective registry study with data being collected continuously for 24 months. Patients who have electocardiographically confirmed atrial fibrillation, are being followed by the Pen Bay Medical Center Anticoagulation Services and are at least 90 years old will be recruited into the study. A matched cohort of patients between the ages of 80 and 89 and another matched cohort of patients between the ages of 70 and 79 will also be recruited into the study for comparison. Data related to adverse events, concomitant medications, living arrangements, mobility and alcohol use will be collected every 6 months. In addition the CHA2DS2-VASc, HAS - BLED, frailty and Mini Cog scores will be recalculated at each visit.</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>70 years of age or older electrocardiographically confirmed atrial fibrillation anticipated regular follow up with patient by PBMC Anticoagulation Services Subject or legally authorized representative must be willing to provide informed consent Patients not being followed by the PBMC Anticoagulation Services</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Elderly</keyword>
	<keyword>Anticoagulation</keyword>
	<keyword>Risk Assessment</keyword>
</DOC>